Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma

被引:404
作者
Gomez, D. [1 ]
Farid, S. [1 ]
Malik, H. Z. [1 ]
Young, A. L. [1 ]
Toogood, G. J. [1 ]
Lodge, J. P. A. [1 ]
Prasad, K. R. [1 ]
机构
[1] St James Univ Hosp, Leeds Teaching Hosp NHS Trust, Hepatobiliary & Transplantat Unit, Leeds LS9 7TF, W Yorkshire, England
关键词
D O I
10.1007/s00268-008-9552-6
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background This study was designed to evaluate the impact of an elevated preoperative neutrophil-to-lymphocyte ratio (NLR) on outcome after curative resection for hepatocellular carcinoma (HCC). Methods Patients undergoing resection for HCC from January 1994 to May 2007 were identified from the hepatobiliary database. Demographics, laboratory analyses, and histopathology data were analyzed. Results A total of 96 patients were identified with a median age at diagnosis of 65 (range, 15-85) years. The 1-, 3-, and 5-year overall survival rates were 80%, 58%, and 52%, respectively. Although the presence of microvascular invasion, NLR >= 5, and R1 resection margin were adverse predictors of overall survival, there were no independent predictors identified on multivariate analysis. The 1-, 3-, and 5-year disease-free survival rates were 74%, 63%, and 57%, respectively. Preoperative tumor biopsy, NLR >= 5, multiple liver tumors, microvascular invasion, and R1 resection margin were all predictors of poorer disease-free survival. Multivariate analysis showed that a NLR >= 5 and R1 resection margin were independent predictors of poorer disease-free survival. The median disease-free survival of those with a NLR >= 5 was 8 months compared with 18 months for those with a NLR < 5. Conclusion Preoperative NLR >= 5 was an adverse predictor of disease-free and overall survival.
引用
收藏
页码:1757 / 1762
页数:6
相关论文
共 44 条
[1]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[2]   Management of hepatoceullular carcinoma [J].
Bruix, J ;
Sherman, M .
HEPATOLOGY, 2005, 42 (05) :1208-1236
[3]   The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer [J].
Canna, K ;
McArdle, PA ;
McMillan, DC ;
McNicol, AM ;
Smith, GW ;
McKee, RF ;
McArdle, CS .
BRITISH JOURNAL OF CANCER, 2005, 92 (04) :651-654
[4]   Antiangiogenic activity of the selective cyclooxygenase 2 inhibitor rofecoxib in human colorectal cancer liver metastases [J].
Chalmers, C. R. ;
Wilson, D. J. ;
Ward, J. ;
Robinson, P. J. ;
Toogood, G. J. ;
Hull, M. A. .
GUT, 2006, 55 (07) :1058-1059
[5]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[6]   Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention [J].
Duffy, BK ;
Gurm, HS ;
Rajagopal, V ;
Gupta, R ;
Ellis, SG ;
Bhatt, DL .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (07) :993-996
[7]   Rising incidence of hepatocellular carcinoma in the United States [J].
El-Serag, HB ;
Mason, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :745-750
[8]   Liver resection for hepatocellular carcinoma on cirrhosis - Univariate and multivariate analysis of risk factors for intrahepatic recurrence [J].
Ercolani, G ;
Grazi, GL ;
Ravaioli, M ;
Del Gaudio, M ;
Gardini, A ;
Cescon, M ;
Varotti, G ;
Cetta, F ;
Cavallari, A .
ANNALS OF SURGERY, 2003, 237 (04) :536-543
[9]   The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases [J].
Fenwick, SW ;
Toogood, GJ ;
Lodge, JPA ;
Hull, MA .
GASTROENTEROLOGY, 2003, 125 (03) :716-729
[10]   p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer [J].
Fondevila, C ;
Metges, JP ;
Fuster, J ;
Grau, JJ ;
Palacín, A ;
Castells, A ;
Volant, A ;
Pera, M .
BRITISH JOURNAL OF CANCER, 2004, 90 (01) :206-215